PSMA-SRT 试验 NCT03582774 更新：一项针对前列腺癌复发挽救性放疗的前列腺特异性膜抗原正电子发射断层扫描的随机 3 期影像学试验，旨在获得临床结局。
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome.
机构信息
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, CA, USA; Physics and Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
出版信息
Eur Urol Focus. 2021 Mar;7(2):238-240. doi: 10.1016/j.euf.2020.12.009. Epub 2020 Dec 30.
Abstract
The purpose of this randomized trial is to evaluate the success rate of salvage radiation therapy for recurrence of prostate cancer after radical prostatectomy, with and without planning based on prostate-specific membrane antigen positron emission tomography/computed tomography. Enrollment has been completed and patients are being followed for 5yr.
摘要
本随机试验旨在评估基于前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描的计划与否对根治性前列腺切除术后前列腺癌复发进行挽救性放疗的成功率。目前已完成入组，正在对患者进行 5 年随访。
相似文献
1
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome.PSMA-SRT 试验 NCT03582774 更新：一项针对前列腺癌复发挽救性放疗的前列腺特异性膜抗原正电子发射断层扫描的随机 3 期影像学试验，旨在获得临床结局。
Eur Urol Focus. 2021 Mar;7(2):238-240. doi: 10.1016/j.euf.2020.12.009. Epub 2020 Dec 30.
2
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774).前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对前列腺癌挽救性放疗管理的影响：一项前瞻性多中心随机 3 期试验（PSMA-SRT NCT03582774）的结果。
Eur Urol. 2024 Jul;86(1):52-60. doi: 10.1016/j.eururo.2024.01.012. Epub 2024 Jan 29.
3
Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial.前列腺切除术后生化复发患者 Ga-PSMA-PET 筛查和放射性核素引导的前列腺床单独挽救性放疗：一项 II 期试验的中期结果。
World J Urol. 2021 Nov;39(11):4117-4125. doi: 10.1007/s00345-021-03735-0. Epub 2021 Jun 2.
4
Vesico-urethral anastomosis sampling: a forgotten tool for guiding salvage radiation after radical prostatectomy.膀胱-尿道吻合口取样：前列腺根治术后挽救性放疗的一种被遗忘的引导工具。
BJU Int. 2021 May;127 Suppl 1:23-29. doi: 10.1111/bju.15315.
5
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy.前列腺切除术治疗后复发或持续性前列腺癌行 PSMA-PET 引导挽救性放疗后的无转移生存和远处转移疾病模式。
Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1015-1024. doi: 10.1016/j.ijrobp.2022.04.048. Epub 2022 Jun 3.
6
Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol.PSMA PET/CT 引导下前列腺癌根治术后生化复发挽救性前列腺床放射治疗的 III 期随机对照试验（PERYTON 试验）：研究方案。
BMC Cancer. 2022 Apr 15;22(1):416. doi: 10.1186/s12885-022-09493-5.
7
(68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.对于正在考虑进行挽救性放射治疗的患者，（68）Ga-PSMA对前列腺窝外前列腺癌复发具有较高的检出率。
BJU Int. 2016 May;117(5):732-9. doi: 10.1111/bju.13397. Epub 2016 Jan 24.
8
Patterns of relapse as determined by Ga-PSMA ligand PET/CT after radical prostatectomy : Importance for tailoring and individualizing treatment.根治性前列腺切除术后 Ga-PSMA 配体 PET/CT 检测复发模式：对治疗方案制定和个体化治疗的重要性。
Strahlenther Onkol. 2018 Apr;194(4):303-310. doi: 10.1007/s00066-017-1231-9. Epub 2017 Nov 13.
9
F-fluciclovine PET-CT and Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.氟[¹⁸F]氟代脱氧葡萄糖 PET-CT 和镓[⁶⁸Ga]前列腺特异性膜抗原-11 PET-CT 在前列腺癌根治术后早期生化复发患者中的应用：一项前瞻性、单中心、单臂、对比成像试验。
Lancet Oncol. 2019 Sep;20(9):1286-1294. doi: 10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30.
10
Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.前列腺特异性膜抗原标记的镓-68 正电子发射断层扫描/计算机断层扫描检测前列腺癌模型血管靶向光动力治疗后复发。
Eur Urol Focus. 2021 Mar;7(2):472-478. doi: 10.1016/j.euf.2019.06.008. Epub 2019 Jun 18.
引用本文的文献
1
PET imaging utilization and trends in Germany: a comprehensive survey.德国正电子发射断层扫描成像的使用情况与趋势：一项全面调查
Eur J Nucl Med Mol Imaging. 2025 May 3. doi: 10.1007/s00259-025-07323-x.
2
Long-term outcomes of PSMA PET/CT-guided radiotherapy in biochemical failure patients post-radical prostatectomy: a 5-year follow-up analysis.前列腺特异性膜抗原（PSMA）正电子发射断层扫描/计算机断层扫描（PET/CT）引导下的放疗对根治性前列腺切除术后生化复发患者的长期疗效：一项5年随访分析
Eur J Nucl Med Mol Imaging. 2025 Apr 5. doi: 10.1007/s00259-025-07255-6.
3
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer.在前列腺癌生化复发患者中，游离DNA片段化模式与通过PSMA PET/CT体积参数测量的肿瘤负荷相关。
EJNMMI Res. 2024 Dec 18;14(1):124. doi: 10.1186/s13550-024-01170-x.
4
Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.一种新型列线图的开发与内部验证，该列线图用于预测在重新分期的前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描中无转移的前列腺癌根治术后生化复发患者挽救性放射治疗的结果。
Eur Urol Open Sci. 2024 Feb 6;61:37-43. doi: 10.1016/j.euros.2024.01.009. eCollection 2024 Mar.
5
Impact of PSMA PET on Prostate Cancer Management.PSMA PET 对前列腺癌管理的影响。
Curr Treat Options Oncol. 2024 Feb;25(2):191-205. doi: 10.1007/s11864-024-01181-9. Epub 2024 Jan 25.
6
Clinical practice in prostate PET imaging.前列腺PET成像的临床实践。
Ther Adv Med Oncol. 2023 Nov 22;15:17588359231213618. doi: 10.1177/17588359231213618. eCollection 2023.
7
Detection of Biochemically Recurrent Prostate Cancer with [F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters.使用[F]DCFPyL PET/CT 检测生化复发前列腺癌：一项更新的系统评价和荟萃分析，重点关注与血清前列腺特异性抗原参数的相关性。
Tomography. 2023 Aug 15;9(4):1504-1514. doi: 10.3390/tomography9040120.
8
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment.既往挽救性治疗后寡转移进展的前列腺癌患者中基于PSMA-PET引导的治疗
Cancers (Basel). 2023 Mar 29;15(7):2027. doi: 10.3390/cancers15072027.
9
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.根治性前列腺切除术后挽救性治疗时前列腺特异性抗原水平与死亡风险。
J Clin Oncol. 2023 May 1;41(13):2428-2435. doi: 10.1200/JCO.22.02489. Epub 2023 Mar 1.
10
Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines.基于 Ga-PSMA PET/CT 的前列腺床根治性前列腺切除术后复发图谱：挽救性放疗勾画指南的临床意义。
J Nucl Med. 2023 Jun;64(6):902-909. doi: 10.2967/jnumed.122.265025. Epub 2023 Feb 9.
本文引用的文献
1
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.辅助或早期挽救性放疗治疗局限性和局部进展性前列腺癌：汇总数据的前瞻性计划系统评价和荟萃分析。
Lancet. 2020 Oct 31;396(10260):1422-1431. doi: 10.1016/S0140-6736(20)31952-8. Epub 2020 Sep 28.
2
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.根治性前列腺切除术治疗前列腺癌后的短期雄激素剥夺治疗联合放疗作为挽救治疗（GETUG-AFU 16）：一项 3 期随机试验的 112 个月随访。
Lancet Oncol. 2019 Dec;20(12):1740-1749. doi: 10.1016/S1470-2045(19)30486-3. Epub 2019 Oct 16.
3
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.68Ga-PSMA-11 PET 定位复发性前列腺癌的准确性评估：一项前瞻性单臂临床试验。
JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096.
4
Randomized prospective phase III trial of Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].Ga-PSMA-11 PET/CT 分子影像学在前列腺癌挽救性放疗计划中的随机前瞻性 III 期试验 [PSMA-SRT]。
BMC Cancer. 2019 Jan 7;19(1):18. doi: 10.1186/s12885-018-5200-1.
5
The Utility of PET/CT in the Planning of External Radiation Therapy for Prostate Cancer.正电子发射断层扫描/计算机断层扫描在前列腺癌外放射治疗计划中的应用。
J Nucl Med. 2018 Apr;59(4):557-567. doi: 10.2967/jnumed.117.196444. Epub 2018 Jan 4.
6
Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.在 PSA 水平低于 1.0ng/ml 的 270 例患者中，Ga-PSMA-11 PET/CT 对前列腺癌根治术后生化复发的定位：对挽救性放疗计划的影响。
J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9.
7
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.制定 RTOG 共识指南，以定义前列腺癌术后适形放射治疗的临床靶区。
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):361-8. doi: 10.1016/j.ijrobp.2009.02.006. Epub 2009 Apr 23.
Zotero 插件